MRFR is the Leading Brand in The Research Company who Recently Published Asthma Inhaler Device Market Research Reports which includes Study of growth, Regional Analysis, Top Industry Players Formation, Major Drivers, Upcoming Trends and Forecast to 2022.
Pune, Maharashtra – January 10, 2019 —
The Global Asthma Inhaler Device Market has been observing continued growth and is expected to capture a CAGR of 5.2% over the forecast period of 2017–2023, reveals Market Research Future (MRFR), in a minutely analyzed research report. The high incidence rate of respiratory disorders, particularly COPD and asthma spur the market growth.
High healthcare spending and government strategic and collaborative endeavors to diagnose and manage respiratory health problems also contribute to the growth of the global asthma inhaler devices market. The rise in disposable income and preference for combination therapy for treatment of asthma also boosts market growth. Combination therapy makes use of inhalers for better compliance and reduction of complexity. Complications in inhalation, the high price of devices are limiting the market growth. However, the emergence of novel technologies such as sensor technology which assists in proper inhalation is expected to offer favorable grounds for market growth.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/1653
Global Asthma Inhaler Device Market – Key Players
Some of the key players in this market are
GlaxoSmithKline Plc. (U.K)
Merck & Co., Inc. (US)
Aristopharma Ltd. (Bangladesh)
SRS PHARMACEUTICALS PVT. LTD. (India)
Intas Pharmaceuticals, Ltd. (India)
September 3, 2018: The National Institute for Health and Care Excellence has recently approved a new procedure called bronchial thermoplasty, which is offered to the adults suffering from severe asthma. The procedure has been proven to be safe and can reduce the frequency and severity of attacks.
May 2018, a new asthma device which requires less force to activate has been created by engineers at the University of Cape Town. Named Easy Squeeze, the device is an assistant device for metered-dose asthma inhalers and is easier for children and elderly patient.
In May 2018, SmartAir, a Northern Ireland based health equipment manufacturer, developed a sensor technology named Airbrio, which aids patients to improve their inhalation technique and provides a compliance score.
Feb 2017 BI received expantion of FDA approval of the use of Tiotropium Respimat for treatment of Asthma in Children. With this approval, company will be able to sell the product inside the United States.
Jan 2017 AstraZeneca announced that on 25 January 2017 the US Food and Drug Administration (FDA) granted six months of paediatric exclusivity for Symbicort (budesonide/formoterol) Inhalation Aerosol. Symbicort is approved in the US to treat asthma in patients 12 years and older and for the maintenance and treatment of COPD in adults, the company is expecting larger market share with the product launch.
Nov 2016 Chiesi acquires Atopix therapeutics. The acquisition of the UK based clinical stage biotechnology company will help Chiesi enhance its Asthma Segment.
Feb 2015 AstraZeneca and Actavis Plc have entered into a definitive agreement under which AstraZeneca will acquire the rights to Actavis’ branded respiratory business in the U.S. and Canada for an initial consideration of $600 million on completion and low single-digit royalties above certain revenue threshold.
Global Asthma Inhaler Device Market – Segmentation
The Global Asthma Inhaler Device Market is divided into device type, technology, and end-user.
Based on device type, the market is segmented into metered-dose inhaler, MDI with a spacer, dry-powder inhaler, and others.
Based on technology, the market is segmented into manually operated inhaler devices and digitally operated inhaler devices.
Based on end-user, the market is segmented into hospital, clinics, research institutes, and others.
Global Asthma Inhaler Device Market – Regional Analysis
Depending on geographic region, Globally North America is the largest market for Asthma Inhalers. Currently there are around 6.4% of American suffering from COPD in U.S. and around 5.4 million people suffering from asthma in U.K. This major growth is attributed to the popularity of the dry powder inhalers among population due to its several advantages over Metered Dose Inhalers and other types of inhalers.
Europe is the second-largest market for asthma inhalers. It is observed that almost 70% of the child’s death occurred per year due to respiratory disorders are due to these sudden attacks hence rescue medication or rescue inhalers can serve better to save lots of lives per year.
Browse Complete 80 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/asthma-inhaler-device-market-1653
Asia pacific region is expected to be fastest growing region in respiratory Inhaler market. Middle East & Africa is expected to have limited but steady growth in the market. These countries with the advancement of technology are expected to show large number of cases of asthma and other respiratory disease which remain unnoticed currently.
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/1653
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312
This news is published on Reuters.